The US Supreme Court on Monday temporarily restored access to abortion pill Mifepristone via telehealth and mail.
Justice Samuel Alito granted temporary relief after Mifepristone’s maker, Danco Laboratories and the generic version’s manufacturer, GenBioPro, filed a petition.
Justice Samuel Alito on Monday temporarily halted an appellate court order that blocked a Food and Drug Administration rule allowing the abortion pill mifepristone to be prescribed online and dispensed through the mail.
Alito granted temporary relief to the maker of mifepristone, Danco Laboratories, and the manufacturer of a generic version of the drug, GenBioPro. His administrative stay will remain in place until 5 p.m. on May 11. The move gives the Supreme Court more time to consider the drug companies’ requests to set aside the appellate court’s order while litigation proceeds.
Danco and GenBioPro also asked the high court to take up the case and decide the legal merits. Alito set a Thursday deadline for Louisiana officials to respond to the drugmakers’ emergency appeals.
A federal appeals court on Fridayblockednationwide access to abortion pill prescriptions via telehealth and mail.
A three-judge panel on the Fifth Circuit Court of Appeals unanimously ruled that abortion pills such as Mifepristone must be distributed in person.
Louisiana filed the lawsuit after the FDA allowed Mifepristone to be distributed via telehealth and mail during the Covid pandemic.
In 2023, the ‘Covid’ change to how abortion pills were distributed became permanent.
The American Civil Liberties Union (ACLU) lashed out at Louisiana’s ‘anti-abortion politicians’ after the ruling came down from the appeals court.
Source: The Gateway Pundit
